Can creatine kinase MB levels predict mortality after cardiac surgery?

Nature Clinical Practice Cardiovascular Medicine

Volumn 2, Issue 6, 2005, Pages 280-281

  Jaffe, Allan S ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Coronary artery bypass grafting surgery; Creatine kinase MB

Indexed keywords

CREATINE KINASE MB; PEXELIZUMAB; PLACEBO;

ACUTE HEART INFARCTION; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; SHORT SURVEY;

EID: 20744444264     PISSN: 17434297     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpcardio0218     Document Type: Short Survey

References (5)

1. Crescenzi G et al. (2004) Cardiac biomarker release after CABG with different surgical techniques. J Cardiothorac Vasc Anesth 18: 34-37
2. Caputo M et al. (1997) Cardiac troponin T and troponin I release during coronary artery surgery using cold crystalloid and cold blood cardioplegia. Eur J Cardiothorac Surg 12: 254-260
3. Steuer J et al. (2004) Visualisation and quantification of peri-operative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging. Eur Heart J 25: 1293-1299
4. Apple FS et al. (2002) European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 144: 981-986
5. Babuin L and Jaffe AS: Troponin: the Marker of Choice for the Detection of Cardiac Injury. Canadian Medical J, in press